Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the safety and efficacy of 2% rebamipide compared to placebo in clearing of fluorescein staining of the central cornea in subjects with dry eye disease.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Kubota Vision Inc.
Collaborators
NCT07463950 · Dry Eye Disease (DED)
NCT07412860 · Dry Eye Syndromes, Dry Eye Disease (DED)
NCT07363824 · Dry Eye Disease, Iron
NCT07396441 · Juvenile Open Angle Glaucoma, Dry Eye Disease (DED), and more
NCT05865379 · Dry Eye Disease
East Valley Ophthalmology
Mesa, Arizona
Arizona Center for Clinical Trials, LLC
Phoenix, Arizona
Cornea Consultants of Arizona
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions